The US Bankruptcy Court approved the combined hearing to consider approval on interim basis of modified first amended disclosure statement and plan of Clovis Oncology, Inc. on April 21, 2023. The debtor had filed its modified first amended disclosure statement and plan in the Court on April 20, 2023. The voting record date is April 18, 2023.

The deadline to vote on the plan is May 19, 2023. Any objections to the plan should be made before May 19, 2023, and the confirmation hearing for the plan and disclosure statement has been scheduled for May 25, 2023